Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex K Bonnecaze

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|November 6, 2019
Stress-Dosed Glucocorticoids and Mineralocorticoids Before Intensive Endurance Exercise in Primary Adrenal InsufficiencyAlex K Bonnecaze, Patrick Reynolds, Cynthia A Burns
American Journal of Men'S Health|December 14, 2020
Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 MenAlex K Bonnecaze, Thomas O'Connor, Joseph A Aloi
Journal of General Internal Medicine|May 5, 2021
Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a ReviewAlex K Bonnecaze, Thomas O'Connor, Cynthia A Burns
Cureus|April 15, 2017
Acute Cytomegalovirus (CMV) Infection Associated with Hemophagocytic Lymphohistiocytosis (HLH) in an Immunocompetent Host Meeting All Eight HLH 2004 Diagnostic CriteriaAlex K Bonnecaze, Wesley G Willeford, Peter Lichstein, et al.
BMJ Case Reports|August 5, 2016
Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcomaAlex K Bonnecaze, Sarah Ellen Elza Stephens, Peter John Miller
Southern Medical Journal|March 4, 2017
Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral OxymorphoneMatthew W Wilson, Alex K Bonnecaze, Ajay Dharod, et al.
Hospital Pharmacy|November 1, 2021
Impact of an Interprofessional Collaborative Quality Improvement Initiative to Decrease Inappropriate Thyroid Function TestingAlyssa B Bradshaw, Alex K Bonnecaze, Cynthia A Burns, et al.
Nephrology (Carlton, Vic.)|August 13, 2017
Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO stagingAlex K Bonnecaze, Matthew W Wilson, Ajay Dharod, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|November 6, 2019
Stress-Dosed Glucocorticoids and Mineralocorticoids Before Intensive Endurance Exercise in Primary Adrenal InsufficiencyAlex K Bonnecaze, Patrick Reynolds, Cynthia A Burns
American Journal of Men'S Health|December 14, 2020
Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 MenAlex K Bonnecaze, Thomas O'Connor, Joseph A Aloi
Journal of General Internal Medicine|May 5, 2021
Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a ReviewAlex K Bonnecaze, Thomas O'Connor, Cynthia A Burns
Cureus|April 15, 2017
Acute Cytomegalovirus (CMV) Infection Associated with Hemophagocytic Lymphohistiocytosis (HLH) in an Immunocompetent Host Meeting All Eight HLH 2004 Diagnostic CriteriaAlex K Bonnecaze, Wesley G Willeford, Peter Lichstein, et al.
BMJ Case Reports|August 5, 2016
Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcomaAlex K Bonnecaze, Sarah Ellen Elza Stephens, Peter John Miller
Southern Medical Journal|March 4, 2017
Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral OxymorphoneMatthew W Wilson, Alex K Bonnecaze, Ajay Dharod, et al.
Hospital Pharmacy|November 1, 2021
Impact of an Interprofessional Collaborative Quality Improvement Initiative to Decrease Inappropriate Thyroid Function TestingAlyssa B Bradshaw, Alex K Bonnecaze, Cynthia A Burns, et al.
Nephrology (Carlton, Vic.)|August 13, 2017
Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO stagingAlex K Bonnecaze, Matthew W Wilson, Ajay Dharod, et al.
Pageof 1